About
Sisu Pharma develops drugs that target the cellular stress response by modulating Heat Shock Factor 1 (HSF1), focusing on HSF1 degraders for oncology and activators for neurodegenerative diseases.
Explore Sisu Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.